Clinical Respiratory medicine Flashcards
COPD
Chronic bronchitis and emphysema
Alpha-1-antiprotease deficiency
Inherited enzyme deficiency of alpha-1-antiprotease resulting in emphysema
Chronic bronchitis
Inflamed bronchial tube leading to cough production of sputum most day in at least 3 consecutive months for 2 or more years.
Complicated chronic bronchitis
Acute infective exacerbation of chronic bronchitis - sputum green/yellow
Emphysema
Increased size of airwaves distal to the terminal bronchioles arising from dilation or destructive of alveolar walls and without obvious fibrosis.
Centracinar emphysema
Lossof alveolar walls in upper half of acinar
Panacinar
Massive destruction of acinar, almost all alveolar tissue destroyed
Bullous emphysema
Emphysematous space >1cm, can burst and lead to spontaneous pneumothorax
Peak expiratory flow rate
Simple test that measures peak rate of flow during expiration
Type I respiratory failure
PaO2 <8kPa (CO2 normal or low)
Type II respiratory failure
PaCO2 >6.5kPa (O2 usually low)
Pulmonary hypertension
Increased blood pressure in pulmonary circulation due to vasoconstriction as a result of hypoxic condition
Cor Pulmonale
hypertrophy of the right ventricle of the heart caused by a primary disorder of the respiratory system.
Short acting bronchodilators
SABA (salbutamol and SAMA (ipratropium)
Long acting bronchodilators
LAMA - for COPD (umeclidinium and tioptropium) and LABA (salmeterol)
Asthma
Increased responsiveness of the airways to various stimuli and causes widespread narrowing of airways that changes in severity either spontaneously or as a result of therapy
Atopy
Inherited tendency towards IgE response to allergens
Occupational asthma
Symptoms related to work exposure and no prior history of asthma. Accounts for 10-15% of adult onset asthma, most common in bakers.
Work-excerbated asthma
Asthma symptoms related to work exposure with prior history of asthma.
Pulmonary function test
Lung volume and CO gas transfer tests
Pulsus paradoxus
Change in blood pressure with inspiration/expiration
Leukotriene receptor antagonist
Add on therapy if asthma symptoms not controlled with LABA and ICS alone
Theophylline
Non-Specific phosphodiesterase inhibit and adenosine receptor antagonist. Add on asthma therapy.
‘Wet lung’
Lungs fails to rapidly shift from fluid secreting to fluid absorbing organ at birth
Barker hypothesis
Lung infection shortly after birth restricts total no of alveoli and effects lung function throughout life
Chronic Neonatal Lung Disease
Can develop after RDS and features bronchopulmonary dysplasia. Produces asthma like symptoms and effects lung function later in life.
Respiratory Distress Syndrome
Lack of surfactant production in neonates. Treated with artificial surfactant, oxygen and CPAP.
Primary Microorganisms
Most pathogenic organisms, can infect health and unhealthy people
Facultative Microorganisms
Fairly pathogenic microorganisms - infect people with slightly weakened immune systems
Opportunistic Microorganisms
Only infect people with weakened immune systems
Coryza/Rhinitis
Common cold
Macrophage-mucocillary escalator
Cellular debris and macrophages are moved up out of the respiratory tract by cilia.
Community acquired pneumonia
Pneumonia acquired in primary care
Nosocomial pneumonia
Hospital acquired pneumonia, tends to be more aggressive
Atypical pneumonia
Pneumonia caused by unusual infectious agents
Aspirational pneumonia
Infection by inhalation of gastric contents,
Bronchopneumonia
Diffuse area of infection throughout lung but does not normally affect pleura.
Lobar pneumonia
1 lobe of lung is infected
Hypostatic pneumonia
Collection of fluid in lungs that makes them more susceptible to infection
Obstructive pneumonia
Abscess that obstructs bronchus
Pleurisy
Inflammation of pleura
Empyema
Infection of pleural space
Lung abscess
Collection of pus produced by necrosis of tissue
Pyaemia
Pus forming bacteria in blood
Bronchiectasis
Pathological dilation of bronchi and build up of mucous, most commonly idiopathic
Causes of recurrent lung infection
Local bronchial obstruction, local pulmonary damage (bronchiectasis), generalised lung damage (CF, COPD), non-respiratory disease (HIV, aspiration)
Viral respiratory infectious agents
Adenovirus, influenze A and B, Parainfluenzae I and III, RSV, rhinovirus
Bacterial respiratory agents
Haemophillus influenzae, M catarrhalis, mycoplasma, staph aureus, streptococci
Otitis Media
Infection of ear drum by primary viral infection and then secondary infection with pneumococcus/H. influenzae
Tonsilitis/pharyngitis
Inflammation of tonsils/ back of throat
Stridor
a harsh vibrating noise when breathing, caused by obstruction of the trachea or larynx
Croup
Whooping cough, infection by parainfluenza virus
Pneumonia
Infection of lung tissue (alveoli), most commonly by streptococcus pneumoniae
Purulent sputum
Green/yellow sputum
Pleuritic Chest pain
Sharp pain when breathing in
CURB 65
Severity scoring of pneumonia
Confusion, blood urea >7, respiratory rate >30, diastolic blood pressure <60 and age >65 (1-2 requires hospital, 3-5 requires ITU)
Septicaemia
Infection of blood
Immotile cilia syndrome
Genetic condition causing lack of motile cilia which are unable to clear out mucous. Causes of bronchiectasis
Tracheitis
Infection of trachea causing swelling and constriction , presents similar to croup but with persistent fever and malaise.
Bronchitis
Infection of the bronchi by viral infection and then secondary infection by bacteria due to disrupted mucociliary clearance. Presents with loose rattly cough, self limiting and does not require treatment.
Bronchiolitis
Infection of the bronchioles usually by RSV usually in young children, often confused with asthma. Maximal observation and minimum intervention.
Detection methods of infective organisms
Microscopy and culture of sputum/blood, antigen detection, PCR, serology
Microbiological test for TB
ZN stain, extended culture
Antigen detection methods
Agglutination, ELISA, immuno-fluroescence
Legionella pneumophila
Detection by urinary antigen and sputum culture
Multi-hit theory of carcinogenesis
Between 3-12 genomic changes required to produce invasive phenotype